Piramal Pharma
add_icon

Piramal Pharma

165.95
+2.64
(1.62%)
Market Cap
22,058.87 Cr
PE Ratio
-132.64
Volume
46,47,771.00
Day High - Low
167.88 - 159.00
52W High-Low
240.95 - 148.31
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
22,058.87 Cr
EPS
0.69
PE Ratio
-132.64
PB Ratio
2.68
Book Value
58.28
EBITDA
1,579.60
Dividend Yield
0.09 %
Industry
Healthcare
Return on Equity
1.12
Debt to Equity
0.60
Analyst Rating and Forecast
- By Refinitiv from10 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
US FDA conducted GMP inspection at Piramal Pharma's Digwal facility from February 9-13, 2026, issuing Form-483 with 4 observations related to procedure enhancements, classified as VAI.
negative
Gujarat Pollution Control Board imposes Rs 1 crore interim environmental damage compensation on Piramal Pharma's Dahej facility following earlier closure directions under Water Act provisions.
positive
Piramal Critical Care collaborates with Blue-Zone Technologies to develop waste anaesthetic gas capture and recycling technology, starting in Europe with plans for global expansion.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,697.50
#1 4,07,287.11
37.56
#1 54,729.00
9.71
#1 10,980
16.07
52.49
6,168.50
1,63,754.29
66.27
9,712.00
18.67
2,191
-1.02
48.87
4,078.00
1,38,018.05
64.55
11,539.40
6.99
1,911
30.46
59.36
1,331.50
1,07,554.81
23.69
28,409.50
7.12
5,291
-57.18
35.86
1,268.10
1,05,839.48
19.26
33,741.20
16.73
5,725
-15.28
58.24
2,199.30
1,00,463.76
23.23
22,909.50
13.74
3,306
#1 72.75
56.93
904.70
91,033.99
#1 18.43
23,511.00
18.55
4,615
-0.32
51.32
2,060.50
85,058.49
47.59
12,744.20
#1 20.90
2,007
7.65
42.02
1,145.60
66,536.63
19.29
32,345.60
9.43
3,484
7.59
45.13
5,402.50
64,594.99
29.06
13,458.30
3.70
2,216
10.98
36.02
Growth Rate
Revenue Growth
11.25 %
Net Income Growth
411.80 %
Cash Flow Change
-11.17 %
ROE
386.96 %
ROCE
22.30 %
EBITDA Margin (Avg.)
3.53 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
1,345
1,612
1,709
2,229
1,574
1,777
1,814
2,196
1,802
1,980
2,034
2,591
1,993
2,320
2,233
2,812
2,031
2,124
2,193
Expenses
1,197
1,381
1,314
1,733
1,465
1,554
1,629
1,812
1,617
1,646
1,723
2,053
1,747
1,900
1,867
2,193
1,827
1,885
1,985
EBITDA
148
231
395
495
109
223
185
384
185
334
312
538
246
420
367
619
204
239
208
Operating Profit %
9 %
12 %
15 %
19 %
1 %
10 %
5 %
16 %
8 %
14 %
12 %
20 %
10 %
15 %
15 %
20 %
6 %
8 %
7 %
Depreciation
136
138
147
165
162
166
164
184
174
185
186
196
185
192
197
243
197
203
213
Interest
42
49
50
57
62
83
95
104
119
110
106
114
107
108
103
104
86
82
89
Profit Before Tax
-30
44
198
273
-115
-26
-74
95
-107
40
19
228
-45
120
67
273
-79
-46
-94
Tax
-2
7
35
69
-6
11
17
45
-9
35
9
126
44
98
63
119
3
53
42
Net Profit
-28
37
163
204
-109
-37
-90
50
-99
5
10
101
-89
23
4
154
-82
-99
-136
EPS in ₹
0.00
0.31
1.38
1.72
-0.92
-0.31
-0.76
0.42
-0.83
0.04
0.08
0.77
-0.67
0.17
0.03
1.16
-0.62
-0.75
-1.03

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
10,900
12,797
14,523
15,312
15,678
Fixed Assets
6,106
6,879
7,469
7,990
8,133
Current Assets
3,649
4,067
4,836
5,465
5,797
Capital Work in Progress
627
1,172
1,419
1,116
977
Investments
123
267
639
385
291
Other Assets
4,045
4,478
4,996
5,821
6,277
Total Liabilities
10,900
12,797
14,523
15,312
15,678
Current Liabilities
2,490
3,033
3,843
4,369
3,766
Non Current Liabilities
2,805
3,067
3,906
3,031
3,786
Total Equity
5,605
6,697
6,774
7,911
8,126
Reserve & Surplus
4,610
5,511
5,580
6,588
6,801
Share Capital
995
1,186
1,193
1,323
1,324

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
110
-177
-32
166
-37
Investing Activities
-4,464
-1,737
-1,334
-416
-488
Operating Activities
598
766
484
1,005
892
Financing Activities
3,977
794
818
-422
-441

Share Holding

% Holding
Sept 2022
Oct 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
34.79 %
0.00 %
34.79 %
34.79 %
34.79 %
35.02 %
35.02 %
35.02 %
35.02 %
34.95 %
34.95 %
34.95 %
34.95 %
34.86 %
34.86 %
34.86 %
FIIs
20.00 %
0.00 %
20.00 %
20.00 %
20.00 %
18.04 %
32.37 %
32.51 %
30.59 %
31.42 %
31.73 %
31.68 %
31.49 %
30.86 %
30.27 %
29.66 %
DIIs
4.86 %
0.00 %
5.28 %
4.99 %
5.49 %
7.83 %
8.02 %
9.68 %
12.12 %
12.95 %
13.81 %
14.10 %
14.78 %
14.26 %
14.89 %
15.69 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.42 %
0.00 %
11.80 %
13.94 %
16.77 %
16.81 %
16.95 %
15.57 %
15.13 %
13.94 %
13.29 %
13.29 %
13.11 %
14.07 %
14.12 %
14.11 %
Others
32.92 %
100.00 %
28.14 %
26.29 %
22.95 %
22.30 %
7.64 %
7.22 %
7.14 %
6.74 %
6.22 %
5.98 %
5.66 %
5.95 %
5.86 %
5.69 %
No of Share Holders
1,79,957
1,79,948
2,29,960
2,41,359
2,77,270
2,95,773
2,97,225
2,92,312
2,97,996
3,06,398
3,59,751
4,18,442
4,32,843
4,58,430
4,62,511
4,53,830

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.56 0.00 0.11 0.14 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.84 0.00 0.05 0.08 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
02 Aug 2023 RIGHTS Rights
5:46
02 Aug 2023 101.95 103.86
12 Jul 2024 DIVIDEND Dividend
₹ 0.11 /share
12 Jul 2024 148.05 151.60
26 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Jul 2024 157.10 166.30
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 Oct 2024 221.30 215.15
28 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2025 221.25 224.00
14 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 May 2025 214.95 214.90
16 Jul 2025 DIVIDEND Dividend
₹ 0.14 /share
16 Jul 2025 214.90 216.22
28 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jul 2025 216.88 202.23
30 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2025 199.95 205.61
05 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Nov 2025 203.60 200.42
28 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jan 2026 168.10 152.45

Announcements

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Revocation Of Closure Direction For CompanyS Dahej Site8 hrs ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA Inspection8 hrs ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release8 days ago
Announcement under Regulation 30 (LODR)-Change in Management9 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20159 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 29, 2026
Appointment of Company Secretary and Compliance OfficerJan 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJan 29, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 29, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 29, 2026
Results - Financial Results For The Quarter Ended December 31 2025Jan 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 28, 2026
Announcement Under Regulation 30 (LODR)- Acquisition Of Kenalog® A Branded Commercial Injectable ProductJan 28, 2026
Board Meeting Outcome for Outcome Of Board Meeting Dated January 28 2026Jan 28, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 21, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 16, 2026
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Nine Months Ended 31St December 2025.Jan 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 18, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 17, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 17, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA InspectionDec 11, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 19, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2025
Results - Financial Results For Quarter Ended September 30 2025Nov 05, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated November 5 2025Nov 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Half Year Ended 30Th September 2025.Oct 24, 2025
Announcement under Regulation 30 (LODR)-Credit RatingOct 16, 2025
General - UpdateSep 30, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Sep 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 02, 2025
Sustainability Report - FY2024-25Aug 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 21, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionAug 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 20, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 31, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 29, 2025
Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025Jul 28, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bajaj Finserv Small Cap Fund Direct-Growth
1.19%
686644
0.64%
0.94%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.50%
8301
-0.03%
-0.08%
WhiteOak Capital Equity Savings Fund Direct - Growth
0.00%
-1006
-0.01%
-0.01%
DSP Nifty 500 Index Fund Direct-Growth
0.05%
373
0.05%
0.05%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.50%
355
-0.03%
0.50%
DSP Nifty Healthcare Index Fund Direct-Growth
1.02%
283
-0.06%
-0.13%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.17%
63
-0.01%
0.17%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.05%
30
0.00%
-0.01%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.05%
0
0.00%
0.00%
Axis Nifty 500 Index Fund Direct-Growth
0.05%
0
0.00%
0.00%
Angel One Nifty Total Market Index Fund Direct - Growth
0.05%
0
0.00%
0.00%
Axis Arbitrage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Invesco India Manufacturing Fund Direct-Growth
2.05%
0
0.00%
-0.09%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
1.34%
0
0.00%
-0.08%
Axis Nifty500 Momentum 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bajaj Finserv Flexi Cap Fund Direct-Growth
0.75%
0
0.00%
0.27%
Bajaj Finserv Healthcare Fund Direct-Growth
4.00%
0
0.00%
-0.19%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0.66%
0
0.00%
0.37%
Bandhan Arbitrage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.74%
0
0.00%
-0.04%
Bandhan Nifty 500 Momentum 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Alpha 50 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.50%
0
0.00%
-0.03%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.05%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.78%
0
0.00%
-0.11%

Technical Indicators

RSI(14)
Neutral
50.91
ATR(14)
Less Volatile
5.33
STOCH(9,6)
Neutral
73.68
STOCH RSI(14)
Overbought
97.67
MACD(12,26)
Bullish
1.65
ADX(14)
Weak Trend
19.15
UO(9)
Bearish
60.16
ROC(12)
Uptrend And Accelerating
6.07
WillR(14)
Overbought
-17.81

About Piramal Pharma

Piramal Pharma Limited is an Indian pharmaceutical company incorporated in 2020. It offers a diverse portfolio of products and services through 17 global facilities and distribution in over 100 countries. The company operates through three main segments: an integrated Contract Development and Manufacturing Organization (CDMO) business, a Complex Hospital Generics...more
Chairperson NameNandini Piramal